Back to Top Skip to main content Skip to sub-navigation

DOD vaccinating personnel worldwide against COVID-19

Two soldiers, wearing masks: one is getting a vaccine in his left arm Navy Aviation Boatswain’s Mate 3rd Class Corey Jackson receives the Moderna COVID-19 vaccine from Navy Hospitalman Christopher Wamsley at Naval Station Rota, Spain. U.S. Naval Hospital Rota began administering the vaccine to frontline health care workers and first responders earlier this month. (Photo by Navy Petty Officer 1st Class Nathan Carpenter.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

A little more than a month after the Food and Drug Administration issued emergency use authorization for the Pfizer-BioNTech and Moderna COVID-19 vaccines Dec. 12 and Dec. 17, respectively, vaccines have been increasingly and successfully distributed and administered to Department of Defense personnel worldwide in a safe and effective phased approach.

In the initial controlled distribution and administration phase, DOD delivered its initial allotment of just under 44,000 doses of Pfizer-BioNTech vaccines to 13 select military installations in the continental United States and three international DOD installations.

The 16 DOD locations received their vaccine doses on time and with no loss of product, stated Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, the week the rollout began, allowing for successful administration to prioritized voluntary populations following Centers for Disease Control and Prevention guidance within 24 hours of receipt. The prioritized recipient population in the initial phase (1A) included critical medical staff and first responders on the front lines of the COVID-19 fight to protect them while they continued to care for their patients.

Phase 1A also included Armed Forces Retirement Home residents; health care and support staff at military hospitals and clinics along with non-clinical staff who support patient care with a high risk of exposure; outpatient health care and support personnel, including National Guard and Reserve personnel as well as active-duty service members deploying or supporting COVID-19 response operations. The data-driven, phased approach to vaccination creates a feasible, scalable, and safe plan for effective vaccine distribution, administration, and monitoring.

“It’s important to protect our health, our families, and our community by making the voluntary choice to get the vaccine when it’s made available to you,” said Place. “The vaccine offers the best-known protection from the effects of COVID-19.”

In early January, the distribution plan was expanded to include hundreds more DOD sites around the world to which DOD can now deliver between 25,000 to 30,000 daily doses depending on allocation. As production increases and more personnel choose to receive the vaccine, those numbers are expected to increase daily until the majority of DOD’s 11.1 million personnel can be vaccinated.

“Over 250 DOD immunization sites have received and are administering COVID-19 vaccines,” said Air Force Col. Tanya Rans, chief of the Defense Health Agency’s Immunization Healthcare Division. “DOD is distributing vaccine to immunization sites globally as quickly as possible.”

However, who can get the vaccine may differ at each immunization site based on quantity of vaccine received, desire for a shot by those in the phase, and throughput, she said.

“Some sites have moved from phase 1A to phase 1B, and others have not yet received vaccine,” she added.

The second phase includes national critical capabilities; personnel preparing to deploy outside the continental United States; personnel preparing to deploy in the next three months, including military civilians and contractors authorized to receive immunization from the DOD; beneficiaries age 75 or older; and front-line essential workers, including those in the education and youth and child services staff sector; eligible defense manufacturing, DOD corrections staff; DOD postal service staff; DOD public transit workers; and commissary and other installation food service or agricultural workers. Although most sites are vaccinating phase 1B recipients, each medical treatment facility has the flexibility to move within the population schema according to its population needs and vaccine availability.

“Each service or the U.S. Coast Guard, as appropriate, determines immunization sites and quantity to be received based on the allocation provided to DOD by the Department of Health and Human Services,” said Rans.

As distribution and administration efforts continue with positive responses and minimal reports of adverse reactions from recipients, those in phase 1C are next in line. These include eligible beneficiaries between the ages of 65-74; eligible beneficiaries between 16­64 with increased risk for severe illness as defined by CDC; personnel in the Office of the Secretary of Defense, federal agencies, field activities, Army, Navy, Air Force, Marines, Space Force, Coast Guard, and Reserve component designated as key, essential, or mission-essential; and DOD prisoners.

“Like most vaccines there are some expected adverse effects: Most commonly, soreness at the injection site, headache, and fatigue, but in almost all cases this subsided within two days,” said Place. “We will continue to be fully transparent about our experience within the DOD, and we’ll share that information with the CDC.”

According to the CDC’s COVID Data Tracker, as of Jan. 25—677,025 doses had been distributed among the DOD sites, and 346,180 initial doses had been administered. However, until the risk of the COVID-19 pandemic is reduced based on numbers who have been vaccinated, masks and physical distancing are still necessary for everyone.

“The response from vaccine recipients has been overwhelmingly positive,” said Rans. “The Vaccine Adverse Event Reporting System through CDC is capturing all adverse events reported following receipt of COVID vaccine and will amend clinical recommendations based on any concerns identified.”

“As a physician, I recognize the decision to receive the vaccine is a personal one and the department’s policy is very clear that taking the vaccine is voluntary, but here’s my advice: I encourage you to learn the details of this vaccines’ safety profile,” said Place. “If you have questions, talk to your health care provider. For the huge majority of us, the risk of an adverse event from COVID-19 vaccine is much lower than the short- and long-term risk posed by the disease itself.”

You also may be interested in...

Vaccinations for Adolescents Printed Letter

Infographic
5/14/2021
A graphic saying that the Pfizer-BioNTech vaccine approved for those ages 12 and older. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

An infographic saying that the Pfizer-BioNTech vaccine is approved for those ages 12 and older.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

Vaccinations for Adolescents Flyer

Infographic
5/14/2021
A graphic saying that the Pfizer-BioNTech vaccine approved for those ages 12 and older. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

An infographic saying that the Pfizer-BioNTech vaccine is approved for those ages 12 and older.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

Vaccinations for Adolescents Social Media Post

Infographic
5/14/2021
A social media graphic saying that the Pfizer-BioNTech vaccine approved for those ages 12 and over. Includes a photo of adolescents on the left of the graphic, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

A social media infographic saying that the Pfizer-BioNTech vaccine is approved for those ages 12 and older.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

DHA leadership recognizes, advances 60th MDG mission

Article
5/14/2021
Army Lt. Gen. Ronald Place visits Travis Air Force Base

DHA leadership visit 60th Medical Group at Travis AFB.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit | MHS GENESIS

Teamwork, adaptability, service – MTFs shine during COVID-19 pandemic

Article
5/14/2021
People at screening area

MHS readiness was put to the test at the onset of the COVID-19 pandemic, in early 2020.

Recommended Content:

May Toolkit | May Military and Health Observances | COVID-19 Vaccine Toolkit | Coronavirus

Vaccines Save Lives

Infographic
5/14/2021
Polio and smallpox are almost non-existent because of vaccines. We can eliminate COVID-19 if you get vaccinated. Graphic showing that vaccines work and save lives. Includes a black and white image on the top half listing polio and smallpox on the left hand side. Includes a QR code to schedule vaccination appointments, and the TRICARE logo on the bottom right of the page.

Polio and smallpox are almost non-existent because of vaccines. We can eliminate COVID-19 if you get vaccinated. Graphic showing that vaccines work and save lives. Includes a black and white image on the top half listing polio and smallpox on the left hand side. Includes a QR code to schedule vaccination appointments, and the TRICARE logo on the bottom right of the page.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Promotion

COVID-19 Vaccine Approved for Adolescents Ages 12 and Over

Publication
5/13/2021

The Pfizer-BioNTech vaccine is approved for those ages 12 and over. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

Join Us!! Sixth Live COVID-19 Town Hall

Article
5/12/2021
Image describing today's Town Hall with Dr. Paul Scott and COL Clinton K. Murray, MD.  They are with the Walter Reed Army Institute of Research, and will discuss COVID-19 Vaccine Advancement and Trials.

Join us for today's Town Hall with Dr. Paul Scott and COL Clinton K. Murray, MD. They are with the Walter Reed Army Institute of Research, and will discuss COVID-19 Vaccine Advancement and Trials.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Teleworking New Normal Get out in the Sun

Infographic
5/12/2021
get sun while teleworking

Get sun while teleworking

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

Teleworking New Normal Eat Healthy

Infographic
5/12/2021
eat healthy while teleworking

Eat healthy while teleworking

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

Teleworking New Normal Exercise

Infographic
5/12/2021
excercise while teleworking

Exercise while teleworking

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

Teleworking New Normal Stand Up

Infographic
5/12/2021
stand up while teleworking

Stand up while teleworking

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

Teleworking The New Normal

Infographic
5/12/2021
tools on how to telework during the covid19 social distancing guidance

Tools on how to telework during the COVID-19 social distancing guidance

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

Teleworking New Normal Connect with Others

Infographic
5/12/2021
make connections while teleworking

Make connections while teleworking

Recommended Content:

COVID-19 Vaccine Toolkit | Staying Resilient

COVID19 Screensaver Prevention

Infographic
5/12/2021
COVID Screensaver Prevention

COVID Screensaver Prevention

Recommended Content:

COVID-19 Vaccine Toolkit | Prevent COVID-19
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 37

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.